Screening assay based on nine lipids commonly dysregulated in early-stage lung cancer

Promoting low-dose CT screening among mostly nonsmoking women increased detection of early-stage, but not late-stage, lung cancers

Promoting low-dose CT screening among mostly nonsmoking women increased detection of early-stage, but not late-stage, lung cancers

Blood test based on four-marker protein panel combined with risk prediction model may improve assessment of risk for lung cancer

Compared with 2013 USPSTF criteria, more patients eligible for lung cancer screening with less racial disparity in access

During 2014 to 2018, incidence continued to increase slowly for female breast cancer, remained stable for prostate cancer